SBI Life Insuran Q2 FY27 Earnings Call — Analysis (NSE: SBILIFE)
SBI Life delivered strong H1 FY27 VoNB growth of 19% to ₹3,270 Cr with margins expanding to 27.9%, while reaffirming full-year IRP growth guidance of 14-15%.
Result quality: strong — Earnings grew. Management sentiment: optimistic.
The take
H1FY27 Profit After Tax ₹1270 Cr ( +17% YoY ) . Guidance cut . But missed . New story: Balanced growth with margin focus .
Results
H1 FY27 GWP rose 13% YoY to ₹48,400 Cr, PAT increased 17% YoY to ₹1,270 Cr (or +39% ex-GST), with VoNB up 19% YoY to ₹3,270 Cr and margin at 27.9% (29.3% in Q2).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Gross Written Premium (GWP) | ₹48400 Cr | +13% | yoy · H1FY27 · H1 FY26 |
| New Business Premium (NBP) | ₹20260 Cr | +10% | yoy · H1FY27 · H1 FY26 |
| Individual Rated Premium (IRP) | ₹9720 Cr | +12% | yoy · H1FY27 · H1 FY26 |
| Total APE | ₹11750 Cr | +18% | yoy · H1FY27 · H1 FY26 |
| Individual APE | ₹9770 Cr | +11% | yoy · H1FY27 · H1 FY26 |
| Value of New Business (VoNB) | ₹3270 Cr | +19% | yoy · H1FY27 · H1 FY26 |
| VoNB Margin | 27.9% | none · H1FY27 · 29.3% in Q2FY27 | |
| Profit After Tax | ₹1270 Cr | +17% | yoy · H1FY27 · H1 FY26 |
| Embedded Value | ₹87350 Cr | +15% | yoy · H1FY27 · Sep-25 |
| AUM | ₹530000 Cr | +9% | yoy · H1FY27 · Sep-25 |
| Operating RoEV | 18.8% | none · H1FY27 | |
| Solvency Ratio | 1.97 | point_in_time · H1FY27 · Sep-26 |
Guidance
Management reaffirmed its full-year FY27 guidance of 14% to 15% growth in Individual Rated Premium (IRP) and maintained long-term VoNB margin band at 26-28%.
What management committed to
- [SBI Life's] agency channel will come back to its normal growth in the next couple of months [i.e., Q3/Q4 FY27]. — normal growth, Q3-FY27, Q4-FY27
- [SBI Life] will launch a deferred annuity product in Q3 FY27, with margins similar to or higher than the company's overall VNB margin [~27.9%]. — margin similar to or higher than company margin, Q3-FY27
Key themes
VoNB margin expansion via non-par mix shift
How the narrative shifted
- Balanced growth with margin focus: The margin outperformance is framed as consistent with guidance, not an upgrade; they stick to the range despite beating it.
- Product mix shift to non-ULIP and protection: The mix shift is now backed by actual H1 data, confirming the trend; management set a revised budget of 63% ULIP for the year but is already ahead.
- Agency channel expansion: The slowdown is attributed to month-to-month variation; Q2 weakness is downplayed as temporary, and the long-term commitment to agency is reaffirmed but with less conviction.
- One-off group protection contract masking underlying margin strength: No new details; the GTI impact is treated as a non-recurring item that already reversed in Q2.
- GST impact transitory: The transitory narrative is not reinforced; the absence of explicit 'cease' language suggests the impact may persist longer than previously stated.
- Persistency normalisation post-COVID cohort: The thread is effectively dropped from the prepared remarks; no update on the 61st month cohort.
- Regulatory recalibration opportunity: New thread; no prior narrative. Management stresses that SBI Life is best placed and expects minimal disruption.
- IFRS 17 adoption preparation: First-time mention on this call; no prior narrative. No details on CSM approach yet.
Operational commentary
- Guaranteed non-par savings APE grew 27% to ₹2,470 Cr in H1 FY27, shifting the product mix away from ULIPs (ULIP share declined to 62% from 65% in H1 FY26)
- Group protection APE expanded 134% YoY to ₹1,600 Cr; pure individual protection grew 26% on APE and 29% on sum assured
- Rider attachment reached ~49% of eligible individual policies; individual protection APE including riders grew 30%
- Non-banca distribution channels (direct, web aggregators, brokers, non-SBI banks) grew 67% YoY, contributing 19% of total APE
- Bancassurance channel (SBI + RRBs) contributed 53% of total APE with individual APE at ₹5,990 Cr (+10% YoY)
- Agency channel added 72,000+ agents gross in H1 FY27 and expanded non-ULIP mix from 39% to 47%
- Digital onboarding stood at 99.9% of individual proposals, with 71% processed through automated underwriting
Analyst Q&A
Q. What is driving confidence in achieving the 14-15% full-year IRP guidance given 12% growth in H1 and subdued Q2?
Historically, Q3 and H2 are seasonally stronger quarters for SBI Life; management remains confident that momentum across banca and agency will recover to deliver 14-15% for the full year.
Q. Why did VoNB margin show a negative operating adjustment variance despite positive operating EV experience?
No new assumptions were changed during H1 FY27; the variance reflects normal refinement in assumptions (mortality, persistency, expenses) done in March 2026, which is captured in the YoY walk.
Q. How will the IRDAI distribution consultation paper impact credit life and banca commission structures?
SBI Life maintains uniform commission structures and negligible non-SBI lender credit life business, meaning limited adverse impact and potential market share opportunities as level-playing field norms apply.
Q. Will ULIP CSM release under IFRS be based on sum assured or fund value?
Declined to answer at this stage; management will hold a dedicated investor interaction towards FY27-end to guide on IFRS adoption mechanics.
Research and educational content only. Not investment advice.